Indivior Pharmaceuticals, Inc. Common Stock (INDV) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for INDV. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 18,542,220 | $565M | NEW |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,891,819 | $241M | NEW |
| OAKTREE CAPITAL MANAGEMENT LP | 6,984,102 | $213M | NEW |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,586,576 | $170M | NEW |
| STATE STREET CORP | 4,903,993 | $149M | NEW |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Joseph Ciaffoni (Chief Executive Officer) | SELL | 612,549 | $23M | 2026-06-22 |
| Joseph Ciaffoni (Chief Executive Officer) | EXERCISE | 1,266,903 | 2026-06-22 | |
| Christian Heidbreder (Chief Scientific Officer) | SELL | 18,586 | $707K | 2026-06-11 |
| Ryan Preblick (Chief Financial Officer) | SELL | 36,000 | $1M | 2026-06-08 |
| David E. Wheadon (Director) | AWARD | 10,430 | 2026-05-13 |
Full institutional holdings, insider history, and congressional trades for Indivior Pharmaceuticals, Inc. Common Stock on SentiSense.